Skip to main content
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1992 Aug;49(8):529–531. doi: 10.1136/oem.49.8.529

Incidence of bladder cancer in a cohort of workers exposed to 4-chloro-o-toluidine while synthesising chlordimeform.

W Popp 1, W Schmieding 1, M Speck 1, C Vahrenholz 1, K Norpoth 1
PMCID: PMC1039284  PMID: 1515344

Abstract

Between 1982 and 1990 seven cases of bladder cancer were detected in a group of 49 workers who were synthesising chlordimeform from 4-chloro-o-toluidine. Latency periods ranged from 15 to 23 years. The incidence of bladder tumours in this group was significantly higher than that of the cancer registers of the former GDR, Saarland, and Denmark by factors of 89.7, 53.8, and 35.0 respectively. This provides further evidence that monocyclic aromatic amines such as 4-chloro-o-toluidine may be carcinogenic in humans.

Full text

PDF
531

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Grant D. M., Tang B. K., Kalow W. Polymorphic N-acetylation of a caffeine metabolite. Clin Pharmacol Ther. 1983 Mar;33(3):355–359. doi: 10.1038/clpt.1983.45. [DOI] [PubMed] [Google Scholar]
  2. Kalow W. Variability of caffeine metabolism in humans. Arzneimittelforschung. 1985;35(1A):319–324. [PubMed] [Google Scholar]
  3. Ott M. G., Langner R. R. A mortality survey of men engaged in the manufacture of organic dyes. J Occup Med. 1983 Oct;25(10):763–768. doi: 10.1097/00043764-198310000-00018. [DOI] [PubMed] [Google Scholar]
  4. Popp W., Norpoth K. Kanzerogene Wirkung von Chlordimeform und 4-Chlor-o-toluidin. Dtsch Med Wochenschr. 1991 Sep 20;116(38):1454–1454. [PubMed] [Google Scholar]
  5. Stasik M. J. Carcinomas of the urinary bladder in a 4-chloro-o-toluidine cohort. Int Arch Occup Environ Health. 1988;60(1):21–24. doi: 10.1007/BF00409374. [DOI] [PubMed] [Google Scholar]
  6. Stasik M. J. Harnblasenkrebs durch 4-Chlor-o-toluidin. Dtsch Med Wochenschr. 1991 Sep 20;116(38):1444–1447. doi: 10.1055/s-2008-1063771. [DOI] [PubMed] [Google Scholar]
  7. UEBELIN F., PLETSCHER A. Atiologie und Prophylaxe gewerblicher Tumoren in der Farbstoffindustrie. Schweiz Med Wochenschr. 1954 Aug 7;84(32):917–920. [PubMed] [Google Scholar]
  8. Ward E., Carpenter A., Markowitz S., Roberts D., Halperin W. Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline. J Natl Cancer Inst. 1991 Apr 3;83(7):501–506. doi: 10.1093/jnci/83.7.501. [DOI] [PubMed] [Google Scholar]
  9. Weber W. W., Hein D. W. N-acetylation pharmacogenetics. Pharmacol Rev. 1985 Mar;37(1):25–79. [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES